Low-dose lenalidomide plus cytarabine induce complete remission that can be predicted by genetic profiling in elderly acute myeloid leukemia patients

Molecular Profiling Improves Classification and Prognostication of Nodal Peripheral T-Cell Lymphomas: Results of a Phase III Diagnostic Accuracy Study

(2013) Pier Paolo Piccaluga et al.   JOURNAL OF CLINICAL ONCOLOGY

Combination of Azacitidine and Lenalidomide in Myelodysplastic Syndromes or acute Myeloid Leukemia—a wise Liaison?

(2013) U Platzbecker et al.   LEUKEMIA

Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Alternative novel therapies for the treatment of elderly acute myeloid leukemia patients

(2013) Alessandro Isidori et al.   Expert Review of Hematology

Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia

(2012) D. A. Pollyea et al.   HAEMATOLOGICA

A phase 1 study of concomitant high-dose lenalidomide and 5-azacitidine induction in the treatment of AML

(2012) G Ramsingh et al.   LEUKEMIA

How to manage high-risk acute myeloid leukemia

(2011) E H Estey   LEUKEMIA

Interest of the association azacitidine–lenalidomide as frontline therapy in high-risk myelodysplasia or acute myeloid leukemia with complex karyotype

(2011) E Scherman et al.   LEUKEMIA

Gene expression profiling in MDS and AML: potential and future avenues

(2011) K Theilgaard-Mönch et al.   LEUKEMIA

Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia

(2011) D A Pollyea et al.   LEUKEMIA

A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia

(2010) T. A. Fehniger et al.   BLOOD

Dose Escalation of Lenalidomide in Relapsed or Refractory Acute Leukemias

(2010) William Blum et al.   JOURNAL OF CLINICAL ONCOLOGY

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

(2009) H. Dohner et al.   BLOOD